1049 (Abacavir and Lamivudine 600 mg / 300 mg)
Pill with imprint 1049 is Yellow, Capsule-shape and has been identified as Abacavir and Lamivudine 600 mg / 300 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Abacavir/lamivudine is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Abacavir/lamivudine 600 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1049
Abacavir and Lamivudine
- Imprint
- 1049
- Strength
- 600 mg / 300 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1053
Related Images for "1049"
More about abacavir / lamivudine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 6 Reviews
- Drug class: antiviral combinations
- FDA Alerts (3)
Consumer resources
- Other brands
- Epzicom
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.